Literature DB >> 8383141

Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis.

C Tsigos1, R J Young, A White.   

Abstract

This study has sought to investigate whether diabetic neuropathy is a major determinant of the basal tone of the hypothalamic-pituitary-adrenal axis in diabetes mellitus. We have analyzed the changes in ACTH and cortisol by measuring hourly samples from 0800-1900 h in diabetic patients carefully characterized for the presence of neuropathy. The circadian variation for ACTH and cortisol was normal in these patients. However, integrated secretion (area under the curve) of both ACTH and cortisol was increased specifically in the 25 diabetic patients with symptomatic polyneuropathy (43 +/- 20 pmol/L and 3609 +/- 169 nmol/L, respectively) compared to 19 diabetic patients without neuropathy (30 +/- 10 pmol/L and 2800 +/- 690 nmol/L, respectively) (P < 0.02) and to 11 normal controls (26 +/- 10 pmol/L and 2694 +/- 476 nmol/L, respectively) (P < 0.007). These differences occurred independently of the type of diabetes and were significant for most individual time points. ACTH and cortisol concentrations correlated with most clinical and neurophysiological parameters of neuropathy (P < 0.05-0.001), but not with glycemic control, retinopathy, or proteinuria. Overall, these results suggest that diabetic neuropathy is associated with a specific and persistent increase in the activity of the hypothalamic-pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383141     DOI: 10.1210/jcem.76.3.8383141

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  Decreased glucose tolerance and plasma adiponectin:resistin ratio in a mouse model of post-traumatic stress disorder.

Authors:  T R Castañeda; R Nogueiras; T D Müller; R Krishna; E Grant; A Jones; N Ottaway; G Ananthakrishnan; P T Pfluger; N Chaudhary; M B Solomon; S C Woods; J P Herman; M H Tschöp
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

3.  Organization and Integration of the Endocrine System.

Authors:  George P Chrousos
Journal:  Sleep Med Clin       Date:  2007-06

4.  Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications.

Authors:  Ivana Prpić-Križevac; Silvija Canecki-Varžić; Ines Bilić-Ćurčić
Journal:  Wien Klin Wochenschr       Date:  2012-06-26       Impact factor: 1.704

Review 5.  Glucose metabolism in patients with subclinical Cushing's syndrome.

Authors:  Roberta Giordano; Federica Guaraldi; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Elisa Marinazzo; Andreea Picu; Ezio Ghigo; Emanuela Arvat
Journal:  Endocrine       Date:  2012-03-06       Impact factor: 3.633

Review 6.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

Review 7.  Diabetic autonomic imbalance and glycemic variability.

Authors:  Jesper Fleischer
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

Review 8.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

9.  The longitudinal association of changes in diurnal cortisol features with fasting glucose: MESA.

Authors:  Jenny Pena Dias; Joshua J Joseph; Bjorn Kluwe; Songzhu Zhao; Michelle Shardell; Teresa Seeman; Belinda L Needham; Gary S Wand; David Kline; Guy Brock; Cecilia Castro-Diehl; Sherita Hill Golden
Journal:  Psychoneuroendocrinology       Date:  2020-07-13       Impact factor: 4.905

Review 10.  Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials.

Authors:  Armando P Signore; Feng Zhang; Zhongfang Weng; YanQin Gao; Jun Chen
Journal:  J Neurochem       Date:  2008-05-03       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.